meda ab-a shs
(MEDAA:OMX Nordic Exchange Stockholm)
|Age||Total Calculated Compensation||This person is connected to 12 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Mr. Lennart Perlhagen is the Founder of Meda AB. Mr. Perlhagen served as Chief Executive Officer for Scandinavia and UK for Pfizer where Mr. Perlhagen gained extensive experience in oncology through the launch of the chemotherapy agent doxorubicin (Adriamycin). Mr. Perlhagen helped lead the commercial launch of omeprazole (Losec/ Prilosec), which became the best selling pharmaceutical product in the world for AstroZeneca AB where he served as Regional Director for South ...
Pipers väg 2APhone: 46 86 30 19 00
Solna, Stockholm County 170 09
Fax: 46 86 30 19 50
Board Members Memberships*
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Jean-Paul Clozel M.D.||Founder, Chief Executive Officer and Director|
|Flemming Ornskov M.D., MBA, MPH||Chief Executive Officer, Managing Director and Director|
|Kåre Schultz||Chief Executive Officer and President|
H. Lundbeck A/S
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|Peter Wolpert M.Sc., MScBA||Co-Founder, Chief Executive Officer and President|
Moberg Pharma AB (publ)
|kr2.6M||Compensation as of Fiscal Year 2014.|